ArticleEuropean urology open science2026

PARP Inhibitor Olaparib and Its Combination Therapy in Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Network Meta-analysis.

Yixian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.